Lee, K.; Koo, H.; Kim, Y.; Kim, D.; Son, E.; Yang, H.; Lim, Y.; Hur, M.; Lee, H.W.; Choi, S.W.;
et al. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers 2020, 12, 3210.
https://doi.org/10.3390/cancers12113210
AMA Style
Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, Lim Y, Hur M, Lee HW, Choi SW,
et al. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers. 2020; 12(11):3210.
https://doi.org/10.3390/cancers12113210
Chicago/Turabian Style
Lee, Kyoungmin, Harim Koo, Yejin Kim, Donggeon Kim, Eunju Son, Heekyoung Yang, Yangmi Lim, Minkyu Hur, Hye Won Lee, Seung Won Choi,
and et al. 2020. "Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts" Cancers 12, no. 11: 3210.
https://doi.org/10.3390/cancers12113210
APA Style
Lee, K., Koo, H., Kim, Y., Kim, D., Son, E., Yang, H., Lim, Y., Hur, M., Lee, H. W., Choi, S. W., & Nam, D. -H.
(2020). Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers, 12(11), 3210.
https://doi.org/10.3390/cancers12113210